Sharifi S - Search Results

1

The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine.

Vulpis E, Giulimondi F, Digiacomo L, Zingoni A, Safavi-Sohi R, Sharifi S, Caracciolo G, Mahmoudi M. Vulpis E, et al. Among authors: sharifi s. Mol Pharm. 2021 Jun 7;18(6):2448-2453. doi: 10.1021/acs.molpharmaceut.1c00291. Epub 2021 May 13. Mol Pharm. 2021. PMID: 33983745

2

Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.

Sharifi S, Seyednejad H, Laurent S, Atyabi F, Saei AA, Mahmoudi M. Sharifi S, et al. Contrast Media Mol Imaging. 2015 Sep-Oct;10(5):329-55. doi: 10.1002/cmmi.1638. Epub 2015 Apr 16. Contrast Media Mol Imaging. 2015. PMID: 25882768 Free article. Review.

3

Cell-Imprinted Substrates Modulate Differentiation, Redifferentiation, and Transdifferentiation.

Bonakdar S, Mahmoudi M, Montazeri L, Taghipoor M, Bertsch A, Shokrgozar MA, Sharifi S, Majidi M, Mashinchian O, Hamrang Sekachaei M, Zolfaghari P, Renaud P. Bonakdar S, et al. Among authors: sharifi s. ACS Appl Mater Interfaces. 2016 Jun 8;8(22):13777-84. doi: 10.1021/acsami.6b03302. Epub 2016 May 27. ACS Appl Mater Interfaces. 2016. PMID: 27196338

4

Nanomedicine in Healing Chronic Wounds: Opportunities and Challenges.

Sharifi S, Hajipour MJ, Gould L, Mahmoudi M. Sharifi S, et al. Mol Pharm. 2021 Feb 1;18(2):550-575. doi: 10.1021/acs.molpharmaceut.0c00346. Epub 2020 Jun 10. Mol Pharm. 2021. PMID: 32519875

5

Effect of cell imprinting on viability and drug susceptibility of breast cancer cells to doxorubicin.

Shahriyari F, Janmaleki M, Sharifi S, Hesar ME, Hoshian S, Taghiabadi R, Razaghian A, Ghadiri M, Peirovi A, Mahmoudi M, Nezhad AS, Khademhosseini A. Shahriyari F, et al. Among authors: sharifi s. Acta Biomater. 2020 Sep 1;113:119-129. doi: 10.1016/j.actbio.2020.06.007. Epub 2020 Jun 7. Acta Biomater. 2020. PMID: 32525052

6

Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.

Sharifi S, Caracciolo G, Mahmoudi M. Sharifi S, et al. Trends Pharmacol Sci. 2020 Sep;41(9):641-652. doi: 10.1016/j.tips.2020.06.011. Epub 2020 Jul 23. Trends Pharmacol Sci. 2020. PMID: 32713606 Review.

7

COVID-19: Nanomedicine Uncovers Blood-Clot Mystery.

Saei AA, Sharifi S, Mahmoudi M. Saei AA, et al. Among authors: sharifi s. J Proteome Res. 2020 Nov 6;19(11):4364-4373. doi: 10.1021/acs.jproteome.0c00425. Epub 2020 Aug 31. J Proteome Res. 2020. PMID: 32790309

8

Interdependency of influential parameters in therapeutic nanomedicine.

Kamali Shahri SM, Sharifi S, Mahmoudi M. Kamali Shahri SM, et al. Among authors: sharifi s. Expert Opin Drug Deliv. 2021 Oct;18(10):1379-1394. doi: 10.1080/17425247.2021.1921732. Epub 2021 May 12. Expert Opin Drug Deliv. 2021. PMID: 33887999 Review.

9

The role of sex as a biological variable in the efficacy and toxicity of therapeutic nanomedicine.

Sharifi S, Caracciolo G, Pozzi D, Digiacomo L, Swann J, Daldrup-Link HE, Mahmoudi M. Sharifi S, et al. Adv Drug Deliv Rev. 2021 Jul;174:337-347. doi: 10.1016/j.addr.2021.04.028. Epub 2021 May 4. Adv Drug Deliv Rev. 2021. PMID: 33957181 Review.

10

Restoring Endogenous Repair Mechanisms to Heal Chronic Wounds with a Multifunctional Wound Dressing.

Atashgah RB, Ghasemi A, Raoufi M, Abdollahifar MA, Zanganeh S, Nejadnik H, Abdollahi A, Sharifi S, Lea B, Cuerva M, Akbarzadeh M, Alvarez-Lorenzo C, Ostad SN, Theus AS, LaRock DL, LaRock CN, Serpooshan V, Sarrafi R, Lee KB, Vali H, Schönherr H, Gould L, Taboada P, Mahmoudi M. Atashgah RB, et al. Among authors: sharifi s. Mol Pharm. 2021 Aug 2;18(8):3171-3180. doi: 10.1021/acs.molpharmaceut.1c00400. Epub 2021 Jul 19. Mol Pharm. 2021. PMID: 34279974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

371 results

Search Page